Doctors can examine the genome of a newborn to determine if the child will suffer from any known genetic disorders in the future. (Credit: National Human Genome Research Institute, Wikimedia commons)
Newborn screening relies on whole-genome sequencing to look for genetic, endrocine or metabolic disorders in babies. In a commentary article, the authors provides a list of questions about ethical, legal, and social issues raised by the future of newborn screening. They argue that the child interests should be taken into account when any changes in newborn screening programs are made.
Original research paper published in Science Translational Medicine on March 26, 2014.
Names and affiliations of selected authors
